Characteristics and Outcomes of Psychiatric Inpatients With Severe Mental Illness and COVID-19: Experience From a COVID-19-Specific Acute Psychiatric Ward in Istanbul.

Autor:	Yalçin M; Erenköy Mental and Nervous Diseases Training and Research Hospital, University of Health Sciences, Istanbul., Sönmez Güngör E; Erenköy Mental and Nervous Diseases Training and Research Hospital, University of Health Sciences, Istanbul., Ergelen M; Erenköy Mental and Nervous Diseases Training and Research Hospital, University of Health Sciences, Istanbul., Beşikçi Keleş D; Erenköy Mental and Nervous Diseases Training and Research Hospital, University of Health Sciences, Istanbul., Yerebakan Tüzer M; Erenköy Mental and Nervous Diseases Training and Research Hospital, University of Health Sciences, Istanbul., Öcek Baş T; Erenköy Mental and Nervous Diseases Training and Research Hospital, University of Health Sciences, Istanbul., Güneş M; Erzurum Region Training and Research Hospital, Erzurum., Genç D; Erenköy Mental and Nervous Diseases Training and Research Hospital, University of Health Sciences, Istanbul., Kirşavoğlu B; Bulancak State Hospital, Giresun., Metin M; Gönen State Hospital, Balikesir, Turkey., Bülbül A; Erenköy Mental and Nervous Diseases Training and Research Hospital, University of Health Sciences, Istanbul., Kayacan A; Erenköy Mental and Nervous Diseases Training and Research Hospital, University of Health Sciences, Istanbul.
Jazyk:	angličtina
Zdroj:	The Journal of nervous and mental disease [J Nerv Ment Dis] 2021 Dec 01; Vol. 209 (12), pp. 884-891.
DOI:	10.1097/NMD.0000000000001450
Abstrakt:	Abstract: Recent studies indicated that psychiatric inpatients with severe mental illness (SMI) are at a greater risk of morbidity and mortality from COVID-19. However, there is still little data about the impact of comorbid COVID-19 infection on the course and outcome of acute exacerbations in this population. We conducted a prospective historically matched case control study. The sociodemographic and clinical characteristics of acute psychiatric inpatients with SMI and comorbid COVID-19 (n = 21) were compared with those of historically-matched non-COVID-19 controls with SMI (n = 42). The outcomes for acute inpatients with SMI and COVID-19 were also investigated. The new-onset SMI rate was relatively higher (23.8%) in the COVID-19 group, which has characteristics similar to those of the non-COVID-19 group except for working status (p < 0.05). The COVID-19 group had a high rate of relapse (47.6%) within 6 months of discharge. Our study suggests that patients with SMI who contracted SARS-CoV-2 may have a higher rate of new-onset mental disorder. Considering the high rate of relapse during the pandemic, chronically ill patients with SMI and COVID-19 should be closely monitored after discharge. (Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu